Da Zhou

2.2k total citations · 2 hit papers
30 papers, 1.7k citations indexed

About

Da Zhou is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Da Zhou has authored 30 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Epidemiology and 7 papers in Physiology. Recurrent topics in Da Zhou's work include Liver Disease Diagnosis and Treatment (17 papers), Gut microbiota and health (7 papers) and Diet and metabolism studies (6 papers). Da Zhou is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Gut microbiota and health (7 papers) and Diet and metabolism studies (6 papers). Da Zhou collaborates with scholars based in China, United States and Australia. Da Zhou's co-authors include Qin Pan, Yuanwen Chen, Jian‐Gao Fan, Feng‐Zhi Xin, Jian‐Gao Fan, Haixia Cao, Zehua Zhao, Rui-Nan Zhang, Xiaolin Liu and Rui‐Xu Yang and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Scientific Reports.

In The Last Decade

Da Zhou

29 papers receiving 1.7k citations

Hit Papers

Sodium butyrate attenuates high-fat diet-induced steatohe... 2017 2026 2020 2023 2017 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Da Zhou China 17 1.1k 756 568 267 137 30 1.7k
Yue Yin China 20 715 0.6× 589 0.8× 494 0.9× 216 0.8× 100 0.7× 82 1.6k
Leila Gobejishvili United States 26 1.0k 0.9× 934 1.2× 354 0.6× 283 1.1× 80 0.6× 56 2.2k
Huikuan Chu China 20 780 0.7× 640 0.8× 368 0.6× 160 0.6× 140 1.0× 51 1.5k
Feng‐Zhi Xin China 10 878 0.8× 524 0.7× 398 0.7× 187 0.7× 50 0.4× 12 1.3k
Bruno Ramos‐Molina Spain 22 1.1k 1.0× 360 0.5× 461 0.8× 204 0.8× 78 0.6× 88 1.9k
Janna A. van Diepen Netherlands 24 1.5k 1.3× 1.1k 1.4× 674 1.2× 309 1.2× 54 0.4× 55 3.1k
Junichiro Irie Japan 23 854 0.8× 372 0.5× 712 1.3× 577 2.2× 75 0.5× 80 2.2k
Lionel Fizanne France 11 805 0.7× 899 1.2× 535 0.9× 261 1.0× 82 0.6× 20 1.5k
Aditya Ambade United States 22 779 0.7× 952 1.3× 203 0.4× 252 0.9× 45 0.3× 25 2.1k
Youcai Tang China 20 635 0.6× 325 0.4× 194 0.3× 157 0.6× 54 0.4× 45 1.3k

Countries citing papers authored by Da Zhou

Since Specialization
Citations

This map shows the geographic impact of Da Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da Zhou more than expected).

Fields of papers citing papers by Da Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Da Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da Zhou. The network helps show where Da Zhou may publish in the future.

Co-authorship network of co-authors of Da Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Da Zhou. A scholar is included among the top collaborators of Da Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Da Zhou. Da Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhou, Wei, Ying Fang, Da Zhou, et al.. (2023). Label-Free Detection of T4 Polynucleotide Kinase Activity and Inhibition via Malachite Green Aptamer Generated from Ligation-Triggered Transcription. Biosensors. 13(4). 449–449. 5 indexed citations
3.
Li, Changtao, Lijuan Pang, Fangfang Jin, et al.. (2023). Integrated Network Analysis to Determine CNN1, MYL9, TAGLN, and SORBS1 as Potential Key Genes Associated with Prostate Cancer. Clinical Laboratory. 69(07/2023). 2 indexed citations
4.
Zhu, Yuli, et al.. (2023). A prospective comparison of three ultrasound-based techniques in quantitative diagnosis of hepatic steatosis in NAFLD. Abdominal Radiology. 49(1). 81–92. 10 indexed citations
5.
Shi, Yingying, Chen Yang, Shuai Lü, et al.. (2023). γ‐glutamylcysteine alleviates insulin resistance and hepatic steatosis by regulating adenylate cyclase and IGF‐1R/IRS1/PI3K/Akt signaling pathways. The Journal of Nutritional Biochemistry. 119. 109404–109404. 10 indexed citations
6.
Guo, Cen, et al.. (2022). Gut-brain axis: Focus on gut metabolites short-chain fatty acids. World Journal of Clinical Cases. 10(6). 1754–1763. 53 indexed citations
7.
Yang, Yong‐Yu, Li Xie, Ning‐Ping Zhang, et al.. (2022). Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis. Acta Pharmacologica Sinica. 43(5). 1180–1190. 36 indexed citations
8.
Shi, Yifan, Peng Wang, Da Zhou, et al.. (2022). Multi-Omics Analyses Characterize the Gut Microbiome and Metabolome Signatures of Soldiers Under Sustained Military Training. Frontiers in Microbiology. 13. 827071–827071. 6 indexed citations
9.
Yan, Xintong, et al.. (2021). Citrate activates autophagic death of prostate cancer cells via downregulation CaMKII/AKT/mTOR pathway. Life Sciences. 275. 119355–119355. 19 indexed citations
10.
Zhao, Zehua, Feng‐Zhi Xin, Da Zhou, et al.. (2019). Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats. World Journal of Gastroenterology. 25(20). 2450–2462. 67 indexed citations
11.
Zhao, Zehua, Feng‐Zhi Xin, Yaqian Xue, et al.. (2019). Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats. Experimental & Molecular Medicine. 51(9). 1–14. 251 indexed citations
12.
Yang, Rui‐Xu, Qin Pan, Da Zhou, et al.. (2019). Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis. Lipids in Health and Disease. 18(1). 179–179. 38 indexed citations
13.
Zhou, Da & Jian‐Gao Fan. (2019). Microbial metabolites in non-alcoholic fatty liver disease. World Journal of Gastroenterology. 25(17). 2019–2028. 75 indexed citations
14.
Zhou, Da, Yuanwen Chen, Zehua Zhao, et al.. (2018). Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression. Experimental & Molecular Medicine. 50(12). 1–12. 182 indexed citations
15.
Zhou, Da, Qin Pan, Feng Shen, et al.. (2017). Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota. Scientific Reports. 7(1). 1529–1529. 333 indexed citations breakdown →
16.
Liu, Xiaolin, Haixia Cao, Feng‐Zhi Xin, et al.. (2017). miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1. World Journal of Gastroenterology. 23(46). 8140–8151. 69 indexed citations
17.
Zhou, Da, et al.. (2017). Prolyl oligopeptidase attenuates hepatic stellate cell activation through induction of Smad7 and PPAR-γ. Experimental and Therapeutic Medicine. 13(2). 780–786. 11 indexed citations
18.
Zhou, Da, Qin Pan, Feng‐Zhi Xin, et al.. (2017). Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier. World Journal of Gastroenterology. 23(1). 60–60. 354 indexed citations breakdown →
19.
Li, Zhenghong, et al.. (2016). Galanin receptor 2 mediates antifibrogenic effects of galanin on hepatic stellate cells. Experimental and Therapeutic Medicine. 12(5). 3375–3380. 8 indexed citations
20.
Zhou, Da, Binghang Li, Jing Wang, et al.. (2016). Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line. PLoS ONE. 11(10). e0165224–e0165224. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026